Differential Diagnosis of Acute and Chronic Symptomatic Oral Ulcerations

Total Page:16

File Type:pdf, Size:1020Kb

Differential Diagnosis of Acute and Chronic Symptomatic Oral Ulcerations DIFFERENTIAL DIAGNOSIS OF ACUTE AND CHRONIC SYMPTOMATIC ORAL ULCERATIONS Acute and chronic ulcerations represent the most common symptomatic mucosal pathoses encountered by oral health care practitioners. Every clinician should have an organized approach to these problems which will be encountered frequently. The first step in all cases should be to divide and conquer. The ulcerations can be classified as acute or chronic, and this will cut in half the number of diseases in the differential diagnosis. Acute lesions arise rapidly (1 or 2 days), normally heal in 10-14 days and may recur at varying intervals. In some cases, the lesions may take longer than a month to heal, but this is not typical. Recurrences are highly variable. Some may never recur, while others may recur before the first crop has healed. On the other hand, chronic erosions tend to slowly evolve and become more problematic over an extended period of time. Instead of crops of lesions interspersed with periods of remission, the chronic erosions tend to persist with variable levels of intensity. Patients rarely present to their health care professional when these lesions first arise; the vast majority of chronic ulcerations have been present for months when the patients present for diagnosis and treatment. Normally, the distinction between acute and chronic ulcerations is made easily; but like everything else, there are gray areas. Prior to the development of a differential diagnosis, the patient’s medical history should be evaluated thoroughly. The presence of any extraoral lesions must be documented. A listing of all utilized prescription and “over-the-counter” medications is mandatory. The following is a list of common symptomatic oral ulcerations: ACUTE CHRONIC Recurrent aphthous stomatitis Erosive lichen planus Herpangina Mucous membrane pemphigoid Hand, foot & mouth disease Pemphigus vulgaris Behçet's syndrome Lupus erythematosus Herpes simplex Drug reaction Herpes zoster Contact reaction Erythema multiforme Graft-versus-host disease Necrotizing sialometaplasia Cinnamon reaction Damm Sore Mouth 2 ACUTE ORAL ULCERATIONS 1. Recurrent Aphthous Stomatitis Recurrent aphthous stomatitis (RAS) is the most common pattern of oral ulcerations encountered by the health professional. Approximately 20 percent of the general population has a positive history for these ulcerations. Prevalence as high as 55% has been reported in populations under stress (professional school students). Numerous studies have indicated an immunologic cause. Although the humoral system is involved, the cell mediated immune response has received the most attention and is thought to be responsible for the initiation of the ulceration. Early lesions do show similarity to a delayed hypersensitivity reaction. Investigators theorize RAS is the result of bacterial toxins, foods, and other substances acting as allergens or haptens which initiate an immune response. A variety of allergens most likely is responsible. In addition, mucosal thickness and immunodysregulation appears involved in many patients. Elimination of one allergenic source often resolves RAS in some patients but not in others. Since discovery of the causative agent is most difficult, therapy has been directed toward decreasing the immune reaction. The prototypical and most common form is the minor aphthous stomatitis (MiRAS). These arise almost exclusively on nonkeratinized movable mucosa and exhibit yellow fibrinopurulent membranes surrounded by erythematous halos. The ulcerations vary from 2-10 mm (majority approximately 5 mm) and usually heal without scarring within 10-14 days. The recurrence rate is highly variable. The lesions may number from one to a hundred at a time. Several systemic medical problems can result in lesions clinically identical to RAS and must be ruled out in all cases which are severe or nonresponsive to therapy. A number of systemic disorders such as blood dyscrasia (esp. leukopenia), nutritional deficiencies (low zinc, iron, B12 or folate), Behçet's syndrome, Crohn's disease, celiac sprue and AIDS are associated with an increased prevalence of aphthous-like ulcerations. In addition, every one of the other acute ulcerative conditions may resemble RAS and must be ruled out prior to therapy. Topical steroids appear to be the most consistently efficacious; chemical cautery is contraindicated. Most over- the-counter medications produce more problems than they solve. If clinical contraindications to steroids exist (children, pregnancy, nursing, hypertension, diabetes, granulomatous infectious disease, G.I. ulcerations, blood dyscrasia, previous malignancy, etc.), permission for corticosteroid utilization must be obtained from the attending physician or utilize antimicrobials such as tetracycline or chlorhexidine. In all severe cases and those resistant to normal therapy, a systematic evaluation for the underlying trigger or any related systemic disorders should be performed. THERAPY Localized -Lidex gel (Sore Mouth Solutions [SMS] 1-1). Easy to apply but slightly bitter -Diprolene ointment (SMS 1-2). Thicker than gel but tasteless. Also available as gel but slightly bitter. Often prescribed generically due to difficulty to obtain 15gram tube. Diffuse -Dexamethasone solution (SMS 1-6) Damm Sore Mouth 3 Another type which exhibits significantly more morbidity is the major aphthous stomatitis (MaRAS). This variant also has been called periadenitis mucosa necrotica recurrens or Sutton’s Disease. These ulcerations are similar to MiRAS but are significantly larger, deeper, take longer to heal and result in scarring. The lesions are seen predominantly on movable mucosa, vary in size from one to several centimeters and often take up to six weeks to heal. It is not uncommon for a new lesion to arise before the current ulcer has healed. Long periods of remission are difficult to obtain. The usual topical steroids normally are ineffective. More potent local steroids (Kenacort® tablets, Kenalog 40® Injection, dexamethasone solution) or systemic prednisone often are required for temporary control. All MaRAS patients should be thoroughly evaluated to rule out a systemic basis for their ulcerations. THERAPY Accessible (vestibule, buccal mucosa, etc.): Kenacort tablets (SMS 1-9) Inaccessible (soft palate, tongue, etc.): Compounded dexamethasone solution (SMS 1-7) Extension past wet line: Kenalog 40 injection (SMS 1-10) A relatively rare variant is the herpetiform aphthous stomatitis (HeRAS). These ulcerations appear similar to MiRAS but generally are smaller in size, more numerous and can be found on movable or bound mucosa. The typical size is 2 mm or less, and it is not uncommon for patients to exhibit more than 100 lesions at one time. The recurrences are spaced so closely that the patients are seldom free of these very painful lesions and often have the ulcerations continuously for several years. The lesions frequently cluster and superficially may resemble a primary herpetic infection; the lack of a painful and intensely erythematous gingiva combined with the recurrence history allows separation. Therapy with 2% tetracycline rinse has proved efficacious but, on occasion, is not effective or becomes ineffective with time. A topical corticosteroid is the treatment of choice. 2. Herpangina This is a specific viral infection which can be caused by any one of a number of strains of enterovirus. It normally is seen in young children but may occur in older patients. Once infected, permanent immunity to the infecting strain develops, but an individual can have the disease several times from different strains. By adulthood, most individuals exhibit immunity to several strains. Affected patients present with sore throat, low-grade fever, headache, sometimes vomiting and abdominal pain. The lesions closely resemble RAS and most commonly occur on the soft palate, pharyngeal wall and tonsillar pillars. They normally heal within a week. THERAPY OTC ibuprofen and Sucrets® with dyclonine 3. Hand, Foot & Mouth Disease This is another clinical presentation of enterovirus infection which can be caused by one of several strains. The majority of the cases arise in young children but can present in adulthood. Damm Sore Mouth 4 It is characterized by an erythematous maculopapular rash of the skin which most frequently involves the hands, feet, legs, arms and buttocks. Anorexia, low-grade fever, coryza, sometimes lymphadenopathy, diarrhea, nausea and vomiting can occur. Oral lesions are invariably present and are the principal symptoms in over 90% of the patients. The lesions resemble RAS and occur primarily on the palate, tongue and buccal mucosa. The infection resolves within 10-14 days. Treat like herpangina. 4. Behçet's Syndrome This is a systemic abnormality which most likely is autoimmune and usually arises be- tween the ages of 10 and 45. It is 5-10 times more common in males. Oral, genital, skin and ocular lesions are seen. The oral lesions present as RAS, and the genital ulcers often are small and occur on the scrotum, root of penis, labia majora or perianally. Ocular lesions range from conjunctivitis to uveitis to hypopyon. The skin lesions usually present as pustules on the trunk, limbs or genitalia. A number of other systemic complications may occur also. Classic triad: oral ulcers, genital ulcers and ocular inflammation. If discovered, refer to an experienced dermatologist. 5. Herpes Simplex Infections Classically, herpes simplex is divided into type I in which the infections arise above the waist and type II which is seen below
Recommended publications
  • The Use of Biologic Agents in the Treatment of Oral Lesions Due to Pemphigus and Behçet's Disease: a Systematic Review
    Davis GE, Sarandev G, Vaughan AT, Al-Eryani K, Enciso R. The Use of Biologic Agents in the Treatment of Oral Lesions due to Pemphigus and Behçet’s Disease: A Systematic Review. J Anesthesiol & Pain Therapy. 2020;1(1):14-23 Systematic Review Open Access The Use of Biologic Agents in the Treatment of Oral Lesions due to Pemphigus and Behçet’s Disease: A Systematic Review Gerald E. Davis II1,2, George Sarandev1, Alexander T. Vaughan1, Kamal Al-Eryani3, Reyes Enciso4* 1Advanced graduate, Master of Science Program in Orofacial Pain and Oral Medicine, Herman Ostrow School of Dentistry of USC, Los Angeles, California, USA 2Assistant Dean of Academic Affairs, Assistant Professor, Restorative Dentistry, Meharry Medical College, School of Dentistry, Nashville, Tennessee, USA 3Assistant Professor of Clinical Dentistry, Division of Periodontology, Dental Hygiene & Diagnostic Sciences, Herman Ostrow School of Dentistry of USC, Los Angeles, California, USA 4Associate Professor (Instructional), Division of Dental Public Health and Pediatric Dentistry, Herman Ostrow School of Dentistry of USC, Los Angeles, California, USA Article Info Abstract Article Notes Background: Current treatments for pemphigus and Behçet’s disease, such Received: : March 11, 2019 as corticosteroids, have long-term serious adverse effects. Accepted: : April 29, 2020 Objective: The objective of this systematic review was to evaluate the *Correspondence: efficacy of biologic agents (biopharmaceuticals manufactured via a biological *Dr. Reyes Enciso, Associate Professor (Instructional), Division source) on the treatment of intraoral lesions associated with pemphigus and of Dental Public Health and Pediatric Dentistry, Herman Ostrow Behçet’s disease compared to glucocorticoids or placebo. School of Dentistry of USC, Los Angeles, California, USA; Email: [email protected].
    [Show full text]
  • Routes of Drug Administration
    Routes of Drug Administration Edited by A. T. Florence PhD, DSc, FRSC, FRSE, FRPharmS The School of Pharmacy, University of London, London, UK and E. G. Salole BSc, PhD, MRPharmS Department of Pharmacy, University of Strathclyde, Glasgow, UK WRIGHT London Boston Singapore Sydney Toronto Wellington Wright is an imprint of Butterworth Scientific @l PART OF REED INTERNATIONAL RL.C. All rights reserved. No part of this publication may be reproduced in any material form (including photocopying or storing it in any medium by electronic means and whether or not transiently or incidentally to some other use of this publication) without the written permission of the copyright owner except in accordance with the provisions of the Copyright, Designs and Patents Act 1988 or under the terms of a licence issued by the Copyright Licensing Agency Ltd, 33-34 Alfred Place, London, England WCIE 7DP. Applications for the copyright owner's written permission to reproduce any part of this publication should be addressed to the Publishers. Warning: The doing of an unauthorised act in relation to a copyrigbht work may result in both a civil claim for damages and criminal prosecution. This book is sold subject to the Standard Conditions of Sale of Net Books and may not be re-sold in the UK below the net price given by the Publishers in their current price list. First published 1990 © Butterworth & Co. (Publishers) Ltd, 1990 British Library Cataloguing in Publication Data Routes of drug administration. 1. Medicine. Drug therapy I. Florence, A. T. (Alexander Taylor) II. Salole, E.G. (Eugene G) III.
    [Show full text]
  • Glossary for Narrative Writing
    Periodontal Assessment and Treatment Planning Gingival description Color: o pink o erythematous o cyanotic o racial pigmentation o metallic pigmentation o uniformity Contour: o recession o clefts o enlarged papillae o cratered papillae o blunted papillae o highly rolled o bulbous o knife-edged o scalloped o stippled Consistency: o firm o edematous o hyperplastic o fibrotic Band of gingiva: o amount o quality o location o treatability Bleeding tendency: o sulcus base, lining o gingival margins Suppuration Sinus tract formation Pocket depths Pseudopockets Frena Pain Other pathology Dental Description Defective restorations: o overhangs o open contacts o poor contours Fractured cusps 1 ww.links2success.biz [email protected] 914-303-6464 Caries Deposits: o Type . plaque . calculus . stain . matera alba o Location . supragingival . subgingival o Severity . mild . moderate . severe Wear facets Percussion sensitivity Tooth vitality Attrition, erosion, abrasion Occlusal plane level Occlusion findings Furcations Mobility Fremitus Radiographic findings Film dates Crown:root ratio Amount of bone loss o horizontal; vertical o localized; generalized Root length and shape Overhangs Bulbous crowns Fenestrations Dehiscences Tooth resorption Retained root tips Impacted teeth Root proximities Tilted teeth Radiolucencies/opacities Etiologic factors Local: o plaque o calculus o overhangs 2 ww.links2success.biz [email protected] 914-303-6464 o orthodontic apparatus o open margins o open contacts o improper
    [Show full text]
  • Zeroing in on the Cause of Your Patient's Facial Pain
    Feras Ghazal, DDS; Mohammed Ahmad, Zeroing in on the cause MD; Hussein Elrawy, DDS; Tamer Said, MD Department of Oral Health of your patient's facial pain (Drs. Ghazal and Elrawy) and Department of Family Medicine/Geriatrics (Drs. Ahmad and Said), The overlapping characteristics of facial pain can make it MetroHealth Medical Center, Cleveland, Ohio difficult to pinpoint the cause. This article, with a handy at-a-glance table, can help. [email protected] The authors reported no potential conflict of interest relevant to this article. acial pain is a common complaint: Up to 22% of adults PracticE in the United States experience orofacial pain during recommendationS F any 6-month period.1 Yet this type of pain can be dif- › Advise patients who have a ficult to diagnose due to the many structures of the face and temporomandibular mouth, pain referral patterns, and insufficient diagnostic tools. disorder that in addition to Specifically, extraoral facial pain can be the result of tem- taking their medication as poromandibular disorders, neuropathic disorders, vascular prescribed, they should limit disorders, or atypical causes, whereas facial pain stemming activities that require moving their jaw, modify their diet, from inside the mouth can have a dental or nondental cause and minimize stress; they (FIGURE). Overlapping characteristics can make it difficult to may require physical therapy distinguish these disorders. To help you to better diagnose and and therapeutic exercises. C manage facial pain, we describe the most common causes and underlying pathological processes. › Consider prescribing a tricyclic antidepressant for patients with persistent idiopathic facial pain. C Extraoral facial pain Extraoral pain refers to the pain that occurs on the face out- 2-15 Strength of recommendation (SoR) side of the oral cavity.
    [Show full text]
  • White Lesions of the Oral Cavity and Derive a Differential Diagnosis Four for Various White Lesions
    2014 self-study course four course The Ohio State University College of Dentistry is a recognized provider for ADA, CERP, and AGD Fellowship, Mastership and Maintenance credit. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry. Concerns or complaints about a CE provider may be directed to the provider or to ADA CERP at www.ada.org/goto/cerp. The Ohio State University College of Dentistry is approved by the Ohio State Dental Board as a permanent sponsor of continuing dental education ABOUT this FREQUENTLY asked COURSE… QUESTIONS… Q: Who can earn FREE CE credits? . READ the MATERIALS. Read and review the course materials. A: EVERYONE - All dental professionals in your office may earn free CE contact . COMPLETE the TEST. Answer the credits. Each person must read the eight question test. A total of 6/8 course materials and submit an questions must be answered correctly online answer form independently. for credit. us . SUBMIT the ANSWER FORM Q: What if I did not receive a ONLINE. You MUST submit your confirmation ID? answers ONLINE at: A: Once you have fully completed your p h o n e http://dent.osu.edu/sterilization/ce answer form and click “submit” you will be directed to a page with a . RECORD or PRINT THE 614-292-6737 unique confirmation ID. CONFIRMATION ID This unique ID is displayed upon successful submission Q: Where can I find my SMS number? of your answer form.
    [Show full text]
  • Orally Inhaled & Nasal Drug Products
    ORALLY INHALED & NASAL DRUG PRODUCTS: INNOVATIONS FROM MAJOR DELIVERY SYSTEM DEVELOPERS www.ondrugdelivery.com 00349_GF_OnDrugDelivery349_GF_OnDrugDelivery PulmonaryPulmonary NasalNasal NovemberNovember 2010.indd2010.indd 1 330/11/100/11/10 111:32:331:32:33 “Orally Inhaled & Nasal Drug Products: Innovations from Major Delivery CONTENTS System Developers” This edition is one in the ONdrugDelivery series of pub- Innovation in Drug Delivery by Inhalation lications from Frederick Furness Publishing. Each issue focuses on a specific topic within the field of drug deliv- Andrea Leone-Bay, Vice-President, Pharmaceutical ery, and is supported by industry leaders in that field. Development, Dr Robert Baughman, Vice-President, Clinical Pharmacology & Bioanalytics, Mr Chad EDITORIAL CALENDAR 2011: Smutney, Senior Director, Device Technology, February: Prefilled Syringes Mr Joseph Kocinsky, Senior Vice-President, March: Oral Drug Delivery & Advanced Excipients Pharmaceutical Technology Development April: Pulmonary & Nasal Drug Delivery (OINDP) MannKind Corporation 4-7 May: Injectable Drug Delivery (Devices Focus) June: Injectable Drug Delivery (Formulations Focus) Current Innovations in Dry Powder Inhalers September: Prefilled Syringes Richard Sitz, Technical Manager, DPI Technology October: Oral Drug Delivery Platform Leader November: Pulmonary & Nasal Drug Delivery (OINDP) 3M Drug Delivery Systems 10-12 December: Delivering Biologics (Proteins, Peptides & Nucleotides) Pulmonary Delivery & Dry-Powder Inhalers: SUBSCRIPTIONS: Advances in Hard-Capsule
    [Show full text]
  • Study of Oropharyngeal Ulcers with Their Commonest Anatomical Sites of Presentation Correlated with Histopathological Diagnosis Among the North Bengal Population
    Panacea Journal of Medical Sciences 2020;10(3):258–263 Content available at: https://www.ipinnovative.com/open-access-journals Panacea Journal of Medical Sciences Journal homepage: www.ipinnovative.com Original Research Article Study of oropharyngeal ulcers with their commonest anatomical sites of presentation correlated with histopathological diagnosis among the north Bengal population Tanwi Ghosal (Sen)1, Pallab Kr Saha2,*, Sauris Sen3 1Dept. of Anatomy, North Bengal Medical College, Sushrutanagar, West Bengal, India 2Dept. of Anatomy, NRS Medical College, Kolkata, West Bengal, India 3Dept. of ENT, Jalpaiguri District Hospital, Jalpaiguri, West Bengal, India ARTICLEINFO ABSTRACT Article history: Introduction: Oropharyngeal ulcers are very common in North East part of India due to bad oral habits like Received 31-07-2020 chewing of tobacco etc. A study was performed at North Bengal Medical College and Hospital among the Accepted 06-10-2020 patients attending otorhinolaryngology outdoor to explore the relationship of different types and proportion Available online 29-12-2020 of oropharyngeal ulcers with their commonest anatomical sites and to elicit the relationship with bad oral habits. Aims: • To elicit the different types and proportions of oropharyngeal ulcers. • To explore the relationship Keywords: of different histopathological types with anatomical sites. • To identify the relationship with addiction. Ulcer Material and Methods: This is a Cross-sectional Observational Hospital based study, conducted in the Oral Cavity Otorhinolaryngology outdoor of North Bengal Medical College and Hospital twice a week. 102 patients Oropharynx were selected as study population after maintaining inclusion and exclusion criteria. Anatomical sites Results: The study shows that the most common type of ulcer is aphthous (25.49%) and the least common types are erythroplakia and autoimmune ulcers (1.96%).
    [Show full text]
  • Oral Manifestations of Systemic Disease Their Clinical Practice
    ARTICLE Oral manifestations of systemic disease ©corbac40/iStock/Getty Plus Images S. R. Porter,1 V. Mercadente2 and S. Fedele3 provide a succinct review of oral mucosal and salivary gland disorders that may arise as a consequence of systemic disease. While the majority of disorders of the mouth are centred upon the focus of therapy; and/or 3) the dominant cause of a lessening of the direct action of plaque, the oral tissues can be subject to change affected person’s quality of life. The oral features that an oral healthcare or damage as a consequence of disease that predominantly affects provider may witness will often be dependent upon the nature of other body systems. Such oral manifestations of systemic disease their clinical practice. For example, specialists of paediatric dentistry can be highly variable in both frequency and presentation. As and orthodontics are likely to encounter the oral features of patients lifespan increases and medical care becomes ever more complex with congenital disease while those specialties allied to disease of and effective it is likely that the numbers of individuals with adulthood may see manifestations of infectious, immunologically- oral manifestations of systemic disease will continue to rise. mediated or malignant disease. The present article aims to provide This article provides a succinct review of oral manifestations a succinct review of the oral manifestations of systemic disease of of systemic disease. It focuses upon oral mucosal and salivary patients likely to attend oral medicine services. The review will focus gland disorders that may arise as a consequence of systemic upon disorders affecting the oral mucosa and salivary glands – as disease.
    [Show full text]
  • Chapter 1 Controlling Drug Delivery
    chapter 1 Controlling drug delivery Overview In this chapter we will: & differentiate drug delivery systems according to their physical state & differentiate drug delivery systems according to their route of administration & differentiate drug delivery systems according to their type of drug release & discuss drug transport across epithelial barriers. Introduction KeyPoints & Continued developments in Pharmacotherapy can be defined as the treatment chemistry, molecular biology and prevention of illness and disease by means of and genomics support the drugs of chemical or biological origin. It ranks discovery and developments among the most important methods of medical of new drugs and new drug treatment, together with surgery, physical targets. & treatment, radiation and psychotherapy. There The drug delivery system are many success stories concerning the use of employed can control the pharmacological action of a drugs and vaccines in the treatment, prevention drug, influencing its and in some cases even eradication of diseases pharmacokinetic and (e.g. smallpox, which is currently the only subsequent therapeutic human infectious disease completely profile. eradicated). Although it is almost impossible to estimate the exact extent of the impact of pharmacotherapy on human health, there can be no doubt that pharmacotherapy, together with improved sanitation, better diet and better housing, has improved people’s health, life expectancy and quality of life. Tip Unprecedented developments in genomics Combinatorial chemistry is a way to and molecular biology today offer a plethora of build a variety of structurally related new drug targets. The use of modern chemical drug compounds rapidly and synthetic methods (such as combinatorial systematically. These are assembled chemistry) enables the syntheses of a large from a range of molecular entities number of new drug candidates in shorter times which are put together in different ‘ ’ than ever before.
    [Show full text]
  • Domoso® Solution
    NADA 32-168, Approved by FDA DMSO instilled into the urinary bladder of intact, anesthetized dogs through which an these parameters. DMSO fails to show analgesic or anti-inflammatory activity in certain of In a study designed to evaluate the effects of DOMOSO (dimethyl sulfoxide) Solution at a total enhancement of absorption was demonstrated25. Utilizing a similar technique the transport of these situations, particularly when used by the systemic route or when administered topically daily dose of 100-300 mL administered for a total period of 90 days, no essential or clinically physiologically active insulin across the intact bladder mucosa was demonstrated. Results preceded by an irritant substance. In clinical studies in the horse, it was noted that when meaningful ophthalmological effects were seen in the horse. were judged on a decrease in blood sugar levels over that of controls26. iodine, liniments or other strong irritants were present on the skin from previous therapy and There were no significant variations in glucose, sodium, potassium, SGOT or SGPT DMSO applied, a temporary but marked local reaction would occur. This was due to the In vivo and in vitro methods demonstrated that DMSO enhanced human percutaneous measurements. There were a few fluctuations in hematologic values but no changes appear ability of DMSO to carry these substances into the underlying skin tissues where their irritant ® absorption of various compounds including steroids, vasoconstrictors, antiperspirants and to be drug-related or of significance. DOMOSO SOLUTION actions could be displayed. When DMSO was used clinically, it was applied topically to the dyes, as well as an anthelmintic (thiabendazole) and a skin antiseptic (hexachlorophene)27,28,29,60,61,62.
    [Show full text]
  • Paraneoplastic Pemphigus with Clinical Features of Lichen Planus Associated with Low-Grade B Cell Lymphoma
    Report Paraneoplastic pemphigus with clinical features of lichen planus associated with low-grade B cell lymphoma Sónia Coelho, MD, José Pedro Reis, MD, Oscar Tellechea, MD, PhD, Américo Figueiredo, MD, PhD, and Martin Black, MD, PhD From the Department of Dermatology, Abstract University Hospital, Coimbra, Portugal, St Background Neoplasia-induced lichen planus is described as a cell-mediated reaction to John’s Institute of Dermatology, St Thomas’ unknown epithelial antigens. Paraneoplastic pemphigus (PNP), characterized by the presence Hospital, London, UK of a specific array of autoantibodies, probably represents a different form of presentation of the Correspondence same autoimmune syndrome where the mucocutaneous expression depends on the dominant Sónia Coelho pathologic mechanism. Clínica de Dermatologia, Hospital da Methods The authors report a case of PNP with predominant lichen planus-like lesions and Universidade review the relevant literature. We observed a 74-year-old female with vesico-bullous, erosive, P.3000–075 Coimbra target-shaped and flat papular lichenoid lesions on the lower legs, palms and soles, evolving for Portugal E-mail: [email protected] 3 weeks. Histopathology revealed a lichenoid dermatitis. Direct immunofluorescence showed C3 deposition around keratinocytes and epidermal IgG intranuclear deposition. Indirect immunofluorescence revealed circulating IgG with intercellular staining on rat bladder substrate. Immunoblotting demonstrated bands of 130, 190, 210 and 250 kDa antigens. A pararenal B cell lymphoma was found. Results Oral corticotherapy with 40 mg prednisolone daily was initiated with a good cutaneous response. Four months later, cyclophosphamide (50 mg/day) was introduced because of a discrete enlargement of the pararenal mass. The patient died on the seventh month of follow up as a result of respiratory insufficiency.
    [Show full text]
  • Herpes Simplex Virus Infection
    FUNGI VIRUS BACTERIA DISEASE The oral focal infection theory • A concept generally negleted for several decades, is controversial yet has gained renewed interest with progress in clasification and identification of oral microorganisms. • Additionally, recent evidence associating dental with artherosclerosis and other chronic disease has also helped resurrect the focal infection theory Pathways of infection arising from oral bacteria The three pathway that may link oral bacteria to secondary disease distant from the oral nidus are : 1. Metastatic infection attributable to transient bacteria in the blood 2. Metastatic immunologic injury 3. Metastatic toxic injury The scientific evidence weak a it is best supports of first pathway of transient bacteriemias of oral origin Mechanical prosthetic valve (arrow) Odontogenic infection Caries dental pulpitis Necrosis of the pulp pulp polyp Periapical abscess Periodontal infection Periodontal abscess Gingivitis ANUG Salivary infection Mucositis Recurent Apthous Stomatitis Minor RAS Mayor Fungal infection • Are oral fungal infections common ? • No, most are associated with an underlying systemic condition immunosuppression imunodeficiency syndrome cancer therapy anemia diabetes uremia leukemia • Patients who have conditions that modify the normal oral environment are at increased risk of fungal infection Among these individuals are patients with _ xerostomia _ have taken broad spectrum antibiotics Diagnosis of oral fungal infection based on : • History • Clinical appearance • Culture • Potassium hydroxide
    [Show full text]